Literature DB >> 32898453

Sexual Health in Women.

Juliana M Kling1,2, Stephanie S Faubion2,3, Ekta Kapoor2,4,5.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32898453      PMCID: PMC8322990          DOI: 10.1089/jwh.2020.8730

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


× No keyword cloud information.
  15 in total

Review 1.  The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder.

Authors:  Sheryl A Kingsberg; Anita H Clayton; James G Pfaus
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

2.  Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part II.

Authors:  Sharon J Parish; Andrew T Goldstein; Sue W Goldstein; Irwin Goldstein; James Pfaus; Anita H Clayton; Annamaria Giraldi; James A Simon; Stanley E Althof; Gloria Bachmann; Barry Komisaruk; Roy Levin; Susan Kellogg Spadt; Sheryl A Kingsberg; Michael A Perelman; Marcel D Waldinger; Beverly Whipple
Journal:  J Sex Med       Date:  2016-11-11       Impact factor: 3.802

3.  The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate.

Authors:  Michael Krychman; Shelli Graham; Brian Bernick; Sebastian Mirkin; Sheryl A Kingsberg
Journal:  J Sex Med       Date:  2017-02-12       Impact factor: 3.802

Review 4.  Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review.

Authors:  Irwin Goldstein; Noel N Kim; Anita H Clayton; Leonard R DeRogatis; Annamaria Giraldi; Sharon J Parish; James Pfaus; James A Simon; Sheryl A Kingsberg; Cindy Meston; Stephen M Stahl; Kim Wallen; Roisin Worsley
Journal:  Mayo Clin Proc       Date:  2016-12-01       Impact factor: 7.616

Review 5.  Resistance and barriers to local estrogen therapy in women with atrophic vaginitis.

Authors:  Sheryl A Kingsberg; Michael L Krychman
Journal:  J Sex Med       Date:  2013-03-27       Impact factor: 3.802

6.  Bremelanotide: an overview of preclinical CNS effects on female sexual function.

Authors:  James Pfaus; François Giuliano; Hélène Gelez
Journal:  J Sex Med       Date:  2007-11       Impact factor: 3.802

7.  PT-141: a melanocortin agonist for the treatment of sexual dysfunction.

Authors:  P B Molinoff; A M Shadiack; D Earle; L E Diamond; C Y Quon
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

8.  Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist.

Authors:  James G Pfaus; Annette Shadiack; Tanya Van Soest; Maric Tse; Perry Molinoff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-28       Impact factor: 11.205

9.  Correlates of sexually related personal distress in women with low sexual desire.

Authors:  Raymond C Rosen; Jan L Shifren; Brigitta U Monz; Dawn M Odom; Patricia A Russo; Catherine B Johannes
Journal:  J Sex Med       Date:  2009-03-30       Impact factor: 3.802

10.  Comparison of the Vaginal Microbiomes of Premenopausal and Postmenopausal Women.

Authors:  Karol Gliniewicz; G Maria Schneider; Benjamin J Ridenhour; Christopher J Williams; Yuli Song; Miranda A Farage; Kenneth Miller; Larry J Forney
Journal:  Front Microbiol       Date:  2019-02-14       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.